Impact of the lack of cross-presenting dendritic cells on the generation of inflammatory immune responses in experimental Plasmodium berghei ANKA infection and therapeutic possibilities to limit excessive brain inflammation with doxycycline
Impact of the lack of cross-presenting dendritic cells on the generation of inflammatory immune responses in experimental Plasmodium berghei ANKA infection and therapeutic possibilities to limit excessive brain inflammation with doxycycline
View/Type of Scholarly Publication
DissertationDate of Exam
21.04.2017Date of Publication
21.07.2017Advisor
Hörauf, AchimCo-Referee
Kolanus, WaldemarMetadata
Show full item record
Citable Links 
Abstract
Malaria is a vector-transmitted disease caused by unicellular parasites of the Plasmodium species and resulted in over 400,000 deaths in 2015, most of them in African children below the age of five. Plasmodium parasites are transmitted to a vertebrate intermediate host during blood-meals of female Anopheles mosquitoes, the definitive host of the parasite.
Infections with P. falciparum are responsible for the severest form of malaria in humans, cerebral malaria (CM). CM is thought to be a multi-factorial process, where sequestration of infected erythrocytes and immune cells in the cerebral microvasculature and overwhelming pro-inflammatory immune responses result in severe cerebral damage. Previous research using experimental models revealed that T cells that have been primed in the spleens of infected individuals and migrated to the brain, play an important role in the development of experimental CM. However, the exact mechanisms that lead to CM in some cases of P. falciparum infection remain elusive.
Cross-presenting dendritic cells (DCs) have been shown to be the major cell subset in priming cytotoxic CD8+ T cells during Plasmodium infection. Batf3-/- mice, which genetically lack cross-presenting DCs, are completely protected from experimental CM. We demonstrated here, that the protection was accompanied by reduced immune cell migration to the brain and impaired cytotoxic T lymphocyte (CTL) responses in the spleens of Batf3-/- mice after P. berghei ANKA-infection. Additionally, we found elevated expression of immune regulating factors in these mice, which could further contribute to the ECM-resistance in Batf3-/- mice.
In summary, these results underlined the importance of cross-presenting DCs in the pathogenesis of ECM. Furthermore, they improved our understanding of the disease development by adding important details about the alterations in the immune responses that result from the lack of cross-presenting DCs.
Another important question in understanding ECM pathology is how these immune responses can be modified later in Plasmodium infection, before cerebral symptoms occur, in order to prevent brain inflammation.
The lack of specific treatment of cerebral malaria and increasing drug resistance of Plasmodium species requires new approaches to fight this disease. Here, we demonstrated that the antibiotic doxycycline did not only reduce the parasitemia in P. berghei ANKA infected mice but also generally dampened the pro-inflammatory milieu and antigen-specific cytotoxicity of immune cells in the spleens and brains of infected animals. Different approaches in our experimental setup suggest that the reduced inflammation in doxycycline-treated mice was not exclusively dependent on doxycycline's anti-plasmodial effect. Thus, a combined treatment of doxycycline, which is relatively well-tolerated with few side effects, and another fast-acting anti-parasitic drug might offer a reasonable therapeutic option to target parasite load and cerebral inflammation at the same time.
Infections with P. falciparum are responsible for the severest form of malaria in humans, cerebral malaria (CM). CM is thought to be a multi-factorial process, where sequestration of infected erythrocytes and immune cells in the cerebral microvasculature and overwhelming pro-inflammatory immune responses result in severe cerebral damage. Previous research using experimental models revealed that T cells that have been primed in the spleens of infected individuals and migrated to the brain, play an important role in the development of experimental CM. However, the exact mechanisms that lead to CM in some cases of P. falciparum infection remain elusive.
Cross-presenting dendritic cells (DCs) have been shown to be the major cell subset in priming cytotoxic CD8+ T cells during Plasmodium infection. Batf3-/- mice, which genetically lack cross-presenting DCs, are completely protected from experimental CM. We demonstrated here, that the protection was accompanied by reduced immune cell migration to the brain and impaired cytotoxic T lymphocyte (CTL) responses in the spleens of Batf3-/- mice after P. berghei ANKA-infection. Additionally, we found elevated expression of immune regulating factors in these mice, which could further contribute to the ECM-resistance in Batf3-/- mice.
In summary, these results underlined the importance of cross-presenting DCs in the pathogenesis of ECM. Furthermore, they improved our understanding of the disease development by adding important details about the alterations in the immune responses that result from the lack of cross-presenting DCs.
Another important question in understanding ECM pathology is how these immune responses can be modified later in Plasmodium infection, before cerebral symptoms occur, in order to prevent brain inflammation.
The lack of specific treatment of cerebral malaria and increasing drug resistance of Plasmodium species requires new approaches to fight this disease. Here, we demonstrated that the antibiotic doxycycline did not only reduce the parasitemia in P. berghei ANKA infected mice but also generally dampened the pro-inflammatory milieu and antigen-specific cytotoxicity of immune cells in the spleens and brains of infected animals. Different approaches in our experimental setup suggest that the reduced inflammation in doxycycline-treated mice was not exclusively dependent on doxycycline's anti-plasmodial effect. Thus, a combined treatment of doxycycline, which is relatively well-tolerated with few side effects, and another fast-acting anti-parasitic drug might offer a reasonable therapeutic option to target parasite load and cerebral inflammation at the same time.
Subjects
CD8+ T Zellen, Dendritische Zellen, Doxycyclin, Experimentelle zerebrale Malaria, Immunologie, Plasmodium, Zerebrale Malaria, CD8+ T cells, cerebrale malaria, dendritic cells, doxycycline, experimental cerebral malaria, immunology
Classification (DDC)
570 Biowissenschaften, BiologieKüpper, Janina Melanie: Impact of the lack of cross-presenting dendritic cells on the generation of inflammatory immune responses in experimental Plasmodium berghei ANKA infection and therapeutic possibilities to limit excessive brain inflammation with doxycycline. - Bonn, 2017. - Dissertation, Rheinische Friedrich-Wilhelms-Universität Bonn.
Online-Ausgabe in bonndoc: https://nbn-resolving.org/urn:nbn:de:hbz:5n-47777
Online-Ausgabe in bonndoc: https://nbn-resolving.org/urn:nbn:de:hbz:5n-47777
@phdthesis{handle:20.500.11811/7205,
urn: https://nbn-resolving.org/urn:nbn:de:hbz:5n-47777,
author = {{Janina Melanie Küpper}},
title = {Impact of the lack of cross-presenting dendritic cells on the generation of inflammatory immune responses in experimental Plasmodium berghei ANKA infection and therapeutic possibilities to limit excessive brain inflammation with doxycycline},
school = {Rheinische Friedrich-Wilhelms-Universität Bonn},
year = 2017,
month = jul,
note = {Malaria is a vector-transmitted disease caused by unicellular parasites of the Plasmodium species and resulted in over 400,000 deaths in 2015, most of them in African children below the age of five. Plasmodium parasites are transmitted to a vertebrate intermediate host during blood-meals of female Anopheles mosquitoes, the definitive host of the parasite.
Infections with P. falciparum are responsible for the severest form of malaria in humans, cerebral malaria (CM). CM is thought to be a multi-factorial process, where sequestration of infected erythrocytes and immune cells in the cerebral microvasculature and overwhelming pro-inflammatory immune responses result in severe cerebral damage. Previous research using experimental models revealed that T cells that have been primed in the spleens of infected individuals and migrated to the brain, play an important role in the development of experimental CM. However, the exact mechanisms that lead to CM in some cases of P. falciparum infection remain elusive.
Cross-presenting dendritic cells (DCs) have been shown to be the major cell subset in priming cytotoxic CD8+ T cells during Plasmodium infection. Batf3-/- mice, which genetically lack cross-presenting DCs, are completely protected from experimental CM. We demonstrated here, that the protection was accompanied by reduced immune cell migration to the brain and impaired cytotoxic T lymphocyte (CTL) responses in the spleens of Batf3-/- mice after P. berghei ANKA-infection. Additionally, we found elevated expression of immune regulating factors in these mice, which could further contribute to the ECM-resistance in Batf3-/- mice.
In summary, these results underlined the importance of cross-presenting DCs in the pathogenesis of ECM. Furthermore, they improved our understanding of the disease development by adding important details about the alterations in the immune responses that result from the lack of cross-presenting DCs.
Another important question in understanding ECM pathology is how these immune responses can be modified later in Plasmodium infection, before cerebral symptoms occur, in order to prevent brain inflammation.
The lack of specific treatment of cerebral malaria and increasing drug resistance of Plasmodium species requires new approaches to fight this disease. Here, we demonstrated that the antibiotic doxycycline did not only reduce the parasitemia in P. berghei ANKA infected mice but also generally dampened the pro-inflammatory milieu and antigen-specific cytotoxicity of immune cells in the spleens and brains of infected animals. Different approaches in our experimental setup suggest that the reduced inflammation in doxycycline-treated mice was not exclusively dependent on doxycycline's anti-plasmodial effect. Thus, a combined treatment of doxycycline, which is relatively well-tolerated with few side effects, and another fast-acting anti-parasitic drug might offer a reasonable therapeutic option to target parasite load and cerebral inflammation at the same time.},
url = {https://hdl.handle.net/20.500.11811/7205}
}
urn: https://nbn-resolving.org/urn:nbn:de:hbz:5n-47777,
author = {{Janina Melanie Küpper}},
title = {Impact of the lack of cross-presenting dendritic cells on the generation of inflammatory immune responses in experimental Plasmodium berghei ANKA infection and therapeutic possibilities to limit excessive brain inflammation with doxycycline},
school = {Rheinische Friedrich-Wilhelms-Universität Bonn},
year = 2017,
month = jul,
note = {Malaria is a vector-transmitted disease caused by unicellular parasites of the Plasmodium species and resulted in over 400,000 deaths in 2015, most of them in African children below the age of five. Plasmodium parasites are transmitted to a vertebrate intermediate host during blood-meals of female Anopheles mosquitoes, the definitive host of the parasite.
Infections with P. falciparum are responsible for the severest form of malaria in humans, cerebral malaria (CM). CM is thought to be a multi-factorial process, where sequestration of infected erythrocytes and immune cells in the cerebral microvasculature and overwhelming pro-inflammatory immune responses result in severe cerebral damage. Previous research using experimental models revealed that T cells that have been primed in the spleens of infected individuals and migrated to the brain, play an important role in the development of experimental CM. However, the exact mechanisms that lead to CM in some cases of P. falciparum infection remain elusive.
Cross-presenting dendritic cells (DCs) have been shown to be the major cell subset in priming cytotoxic CD8+ T cells during Plasmodium infection. Batf3-/- mice, which genetically lack cross-presenting DCs, are completely protected from experimental CM. We demonstrated here, that the protection was accompanied by reduced immune cell migration to the brain and impaired cytotoxic T lymphocyte (CTL) responses in the spleens of Batf3-/- mice after P. berghei ANKA-infection. Additionally, we found elevated expression of immune regulating factors in these mice, which could further contribute to the ECM-resistance in Batf3-/- mice.
In summary, these results underlined the importance of cross-presenting DCs in the pathogenesis of ECM. Furthermore, they improved our understanding of the disease development by adding important details about the alterations in the immune responses that result from the lack of cross-presenting DCs.
Another important question in understanding ECM pathology is how these immune responses can be modified later in Plasmodium infection, before cerebral symptoms occur, in order to prevent brain inflammation.
The lack of specific treatment of cerebral malaria and increasing drug resistance of Plasmodium species requires new approaches to fight this disease. Here, we demonstrated that the antibiotic doxycycline did not only reduce the parasitemia in P. berghei ANKA infected mice but also generally dampened the pro-inflammatory milieu and antigen-specific cytotoxicity of immune cells in the spleens and brains of infected animals. Different approaches in our experimental setup suggest that the reduced inflammation in doxycycline-treated mice was not exclusively dependent on doxycycline's anti-plasmodial effect. Thus, a combined treatment of doxycycline, which is relatively well-tolerated with few side effects, and another fast-acting anti-parasitic drug might offer a reasonable therapeutic option to target parasite load and cerebral inflammation at the same time.},
url = {https://hdl.handle.net/20.500.11811/7205}
}
The following license files are associated with this item:
